Home / Stocks / INNV

InnovAge Holding (INNV, Health Care Services) Stock Valuation & Fair Value No P/E valuation

InnovAge Holding (INNV, Health Care Services) trades at a blended P/E of 124.6, trading without a historical P/E to compare against, with a forward growth estimate above 100% and a PEG of 0.73.

This company has no P/E to compare against its own history, so tickerseer publishes no valuation rating for it. The figures below are unaffected.

DATA AS OF 2026-09-21
Blended P/E
124.6
Normal P/E
—
PEG
0.73
Fwd growth
>100%
Div yield
0.0%
RSI (14)
27.4
Oversold
Technical context
  • Price $9.00 at the 2026-09-23 close, 16.0% below the 20-day average ($10.71) and 18.0% below the 50-day ($10.97).
  • RSI (14) at 27.4.
  • 52-week range $3.99 to $12.11: the price is 25.7% below the high and 125.6% above the low.

The Street vs SeerForecast

Wall Street's mean price target for INNV is $12.00 across 2 analysts, 33.3% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: we publish none, because it has no P/E to compare against its own history. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer has published no valuation rating since 2026-09-05, because this company has no P/E to compare against its own history.

Blended P/E and rating by weekBlended P/E moved from 121.6 to 124.6 between 2026-09-05 and 2026-09-21, with 0 rating changes over 6 recorded weeks.2026-09-05: P/E 121.6, No P/E valuation (recalculated)2026-09-07: P/E 121.6, No P/E valuation2026-09-12: P/E 121.6, No P/E valuation (recalculated)2026-09-14: P/E 155.8, No P/E valuation2026-09-19: P/E 155.8, No P/E valuation (recalculated)2026-09-21: P/E 124.6, No P/E valuation130.0140.0150.0Sep 5Sep 9Sep 13Sep 17Sep 21
Attractively valuedNo P/E valuationAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

WeekBlended P/EPremium to normal P/ERating
2026-09-05P/E 121.6not availableNo P/E valuation
2026-09-07P/E 121.6not availableNo P/E valuation
2026-09-12P/E 121.6not availableNo P/E valuation
2026-09-14P/E 155.8not availableNo P/E valuation
2026-09-19P/E 155.8not availableNo P/E valuation
2026-09-21P/E 124.6not availableNo P/E valuation ← now

Frequently asked questions

Is InnovAge Holding stock overvalued?

At a blended P/E of 124.6, InnovAge Holding has no historical normal P/E on record to compare that against, with a PEG of 0.73 on forward growth above 100%. tickerseer therefore publishes no valuation rating for it.

What is InnovAge Holding's fair value and PEG?

InnovAge Holding trades at a blended P/E of 124.6, a PEG of 0.73, and a forward growth estimate above 100%.

Has tickerseer's rating of InnovAge Holding changed?

tickerseer has published no valuation rating since 2026-09-05, because this company has no P/E to compare against its own history.

What is the analyst price target for InnovAge Holding?

The mean Wall Street price target for InnovAge Holding is $12.00 across 2 analysts, 33.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track INNV free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.